We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

59 hedge funds and large institutions have $51M invested in Avadel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.9% less ownership

Funds ownership: 50.31% → 49.41% (-0.9%)

9% less funds holding

Funds holding: 65 → 59 (-6)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

42% less capital invested

Capital invested by funds: $88.5M → $51M (-$37.5M)

63% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $76K

Holders
59
Holders Change
-6
Holders Change %
-9.23%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
19
Closed
17
Calls
–
Puts
$76K
Net Calls
-$76K
Net Calls Change
+$118K

Top Buyers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
+$2.66M
2
FI
Fosun International
China
+$1.15M
3
BC
Broadfin Capital
New York
+$1.05M
4
Ameriprise
Ameriprise
Minnesota
+$616K
5
HCM
Highbridge Capital Management
New York
+$333K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$2.56M
2
BlackRock
BlackRock
New York
-$2.12M
3
GTC
Ghost Tree Capital
New York
-$1.98M
4
PCM
Portolan Capital Management
Massachusetts
-$661K
5
AA
ALPS Advisors
Colorado
-$311K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIP
1
Brandes Investment Partners
California
$18.4M +$2.66M +783,506 +12%
BC
2
Broadfin Capital
New York
$8.01M +$1.05M +309,900 +11%
DM
3
Deerfield Management
New York
$7.02M – – –
BCM
4
Brown Capital Management
Maryland
$2.83M +$291K +85,700 +8%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$2.79M -$134K -39,338 -4%
TCM
6
Tekla Capital Management
Massachusetts
$2.1M – – –
Morgan Stanley
7
Morgan Stanley
New York
$1.86M -$188K -55,253 -7%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.6M +$144K +42,365 +7%
Ameriprise
9
Ameriprise
Minnesota
$1.3M +$616K +181,285 +56%
JAM
10
JW Asset Management
Florida
$1.15M – – –
FI
11
Fosun International
China
$826K +$1.15M +337,043 New
Janney Montgomery Scott
12
Janney Montgomery Scott
Pennsylvania
$366K -$291K -85,717 -38%
HCM
13
Highbridge Capital Management
New York
$253K +$333K +98,000 New
Citadel Advisors
14
Citadel Advisors
Florida
$250K -$83.2K -24,455 -20%
State Street
15
State Street
Massachusetts
$230K – – –
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$218K -$20.1K -5,901 -7%
COPPSERS
17
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$201K – – –
Millennium Management
18
Millennium Management
New York
$189K +$249K +73,121 New
CS
19
Candriam SCA
Luxembourg
$160K – – –
PAM
20
Panagora Asset Management
Massachusetts
$153K +$157K +46,115 +354%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$118K -$73.8K -21,696 -32%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$95K – – –
EVM
23
Eaton Vance Management
Massachusetts
$90K – – –
IAMOG
24
Investors Asset Management of Georgia
Georgia
$88K +$6.8K +2,000 +6%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$86K -$10.2K -3,007 -8%
1
2 3

AVDL Hedge Fund Activity: Q4 2018 in Review

59 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2018, worth a combined $51M — down 42% from $88.5M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of AVDL and 11 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 7 added.

The largest buyer was Brandes Investment Partners, adding an estimated $2.66M. The largest seller was Deutsche Bank, cutting an estimated $2.56M.

  • 59 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2018, down from 65 in Q3 2018.
  • Funds reported $51M of Avadel Pharmaceuticals stock for Q4 2018, down 42% quarter-over-quarter.
  • 11 funds opened new Avadel Pharmaceuticals positions in Q4 2018 and 17 closed out, a net change of -6 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2018 was Brandes Investment Partners, an estimated $2.66M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2018 was Deutsche Bank, an estimated $2.56M sold.

Based on aggregated 13F filings for Q4 2018.